herp
simplex
viru
type
present
brain
carrier
type
allel
apolipoprotein
e
gene
apo
implic
major
factor
alzheim
diseas
ad
propos
viru
normal
latent
mani
elderli
brain
reactiv
period
peripher
nervou
system
certain
condit
exampl
stress
immunosuppress
peripher
infect
caus
cumul
damag
eventu
develop
ad
divers
approach
provid
data
explicitli
support
directli
indirectli
concept
sever
confirm
dna
presenc
human
brain
associ
ad
studi
apoetransgen
mice
shown
anim
display
greater
potenti
viral
damag
reactiv
caus
direct
inflammatori
damag
probabl
involv
increas
format
beta
amyloid
adlik
tau
ptau
chang
found
occur
cell
cultur
implic
ad
discoveri
dna
specif
local
amyloid
plaqu
ad
relev
harm
effect
infect
includ
follow
dynam
interact
amyloid
precursor
protein
app
would
affect
viral
app
transport
induct
tolllik
receptor
tlr
astrocyt
cultur
link
like
effect
reactiv
viru
brain
sever
epidemiolog
studi
shown
use
serolog
data
associ
system
infect
cognit
declin
particularli
implic
genet
studi
link
variou
pathway
ad
occur
infect
relat
potenti
usag
antivir
treat
ad
patient
acyclovir
acv
effect
reduc
adlik
chang
cell
cultur
valacyclovir
bioactiv
form
acv
might
effect
combin
antivir
act
differ
mechan
intraven
immunoglobulin
ivig
concept
viral
role
alzheim
diseas
ad
specif
herp
simplex
viru
type
first
propos
sever
decad
ago
ball
gannicliff
et
al
legitim
concept
clearli
depend
posit
answer
number
test
question
first
whether
ever
present
human
brain
subsequ
discoveri
dna
resid
high
proport
brain
elderli
peopl
latent
form
jamieson
et
al
normal
ad
patientsimmedi
made
concept
credibl
rais
associ
question
whether
viru
ever
activ
brain
mere
passiv
resid
whether
caus
factor
ad
act
thu
anoth
factor
perhap
genet
activ
caus
activ
whether
link
characterist
abnorm
featur
ad
brain
compon
whether
inde
implic
ad
antivir
agent
would
use
treat
diseas
question
pose
previou
review
wozniak
itzhaki
strong
evid
present
permit
answer
question
ye
like
ye
present
review
briefli
summar
earlier
evid
provid
updat
especi
time
view
subsequ
steadi
increas
number
relev
public
contrast
high
frequenc
dna
elderli
brain
viral
dna
found
present
small
proport
brain
young
peopl
children
wozniak
et
al
wozniak
et
al
therefor
suggest
enter
brain
older
age
consequ
declin
immun
system
age
subsequ
found
viru
brain
carrier
allel
confer
strong
risk
factor
ad
itzhaki
et
al
account
case
evid
obtain
indic
reactiv
brain
caus
product
infect
perhap
recurr
wozniak
et
al
activ
infect
caus
sever
damag
usual
lead
cell
death
therefor
suggest
might
period
reactiv
brain
episod
stress
immunosuppress
inflamm
caus
cumulativethough
necessarili
limit
local
damagewhich
greater
carrier
lead
eventu
develop
ad
reactiv
event
long
known
occur
peripher
nervou
system
resid
lifelong
trigemin
ganglia
caus
overt
damag
form
cold
sore
herp
labiali
infect
wherea
other
remain
asymptomatican
enigma
solv
work
author
laboratori
itzhaki
et
al
see
subsequ
confirm
anoth
koell
et
al
effect
directinclud
subvert
cell
machineri
produc
viral
instead
cellular
compon
indirect
via
inflammatori
process
neuropatholog
process
lead
diseasewhich
gener
acknowledg
multifactorialar
unknown
howev
case
act
might
occur
via
viru
known
abil
caus
accumul
beta
amyloid
adlik
tau
ptau
main
compon
respect
characterist
amyloid
plaqu
neurofibrillari
tangl
nft
ad
brain
see
itzhaki
wozniak
sever
studi
add
support
scheme
firstli
apo
found
modul
sever
diseas
suscept
infect
case
sever
diseas
microbi
caus
includ
two
caus
herp
simplex
viru
type
name
herp
labiali
itzhaki
et
al
genit
herp
jayasuriya
et
al
risk
factor
parallel
propos
role
risk
ad
cn
secondli
dna
locat
specif
within
characterist
amyloid
plaqu
ad
brain
wozniak
et
al
reactiv
brain
obvious
lead
overt
herp
simplex
enceph
hse
outcom
would
probabl
fatal
unless
diagnos
rapidli
treat
immedi
antivir
therefor
reactiv
event
must
presum
local
mild
fact
limit
asymptomat
reactiv
describ
number
case
recurr
hse
see
consist
concept
viral
role
ad
least
two
virus
measl
human
immunodefici
viru
hiv
caus
chang
brain
similar
characterist
ad
measl
viru
year
initi
infect
lead
rare
sever
diseas
subacut
scleros
panenceph
nft
appear
brain
wisniewski
et
al
hiv
infect
lead
format
adlik
tau
anthoni
et
al
also
postencephalit
parkinson
thought
caus
viru
character
nft
et
al
last
year
mani
studi
publishedsom
group
authorsus
divers
approach
yield
divers
type
inform
explicitli
support
consist
propos
role
ad
contrast
public
describ
contradictori
data
set
studi
describ
though
briefli
case
cite
two
previou
review
wozniak
itzhaki
itzhaki
wozniak
worth
mention
despit
preponder
support
data
concept
viral
role
diseas
still
regard
controversi
probabl
certain
aspect
relat
viru
behavior
inde
microbi
behaviorar
either
understood
consid
even
recogn
research
field
inde
long
histori
resist
concept
microbi
involv
certain
chronic
diseas
even
incontrovert
experiment
evid
obtain
exampl
peyton
rou
discov
cancerproduc
viru
dulbecco
first
two
aspect
microbi
action
need
recogn
microb
caus
acut
infectionsact
hitandrun
agentsfli
caus
damag
fli
bodi
caus
chronic
diseas
fact
certain
microb
remain
bodi
lifelong
mainli
dormant
state
occasion
eventu
becom
activ
caus
damag
sometim
sever
even
fatal
host
second
aspect
respons
microbesuscept
infect
andor
extent
damag
caus
infect
ensuescan
differ
person
person
determin
genet
factor
immun
respons
thu
outcom
rang
uninfect
asymptomat
infect
sever
fatal
ill
likelihood
asymptomat
person
would
class
control
despit
harbor
microb
inde
diseas
proport
infect
patient
control
group
similar
word
infect
necessarili
mean
affect
research
object
viral
role
invok
first
koch
postulatesthat
microorgan
must
found
abund
organ
suffer
diseas
found
healthi
organismsa
argument
concept
howev
koch
realiz
postul
invalid
fact
microb
caus
asymptomat
infect
case
postul
appli
virus
need
modifi
sever
respect
virus
independ
organ
instead
multipli
within
cell
review
deal
updat
topic
cover
author
recent
review
also
topic
cover
previous
name
possibl
cytomegaloviru
cmv
rather
caus
ad
epidemiolog
studi
humor
respons
genet
studi
evid
reactiv
cn
effect
infect
mous
brain
ptau
studi
cell
cultur
case
antivir
treatment
ad
patient
possibl
cmv
anoth
member
herp
famili
virus
rather
major
factor
ad
consid
number
public
base
mani
studi
implic
viru
immunosenesc
although
said
role
latter
unexplain
mani
aspect
controversi
howev
presum
obviou
requirementth
presenc
cmv
brain
ad
patientsha
establish
contrast
dna
found
human
brain
seven
independ
group
includ
author
latter
use
three
differ
method
solut
situ
pcr
immunolog
sole
contradictori
studi
two
detect
dna
small
percentag
subject
third
show
trend
associ
confer
risk
ad
find
review
wozniak
itzhaki
gener
point
consid
itzhaki
et
al
brain
describ
truli
virusneg
base
analys
necessarili
small
specimen
kg
organ
first
studi
seek
cmv
taylor
crow
use
prepcr
techniqu
dna
hybridis
state
detect
limit
one
viral
genom
per
cell
howev
neither
cmv
found
normal
ad
brain
studi
author
laboratori
sought
cmv
dna
pcr
detect
ad
brain
agematch
control
lin
et
al
howev
stress
valu
might
artefactu
high
account
could
taken
viru
resid
lymphocyt
within
blood
vessel
rather
brain
cell
interestingli
cmv
dna
detect
much
higher
brain
vascular
dementia
patient
lin
et
al
fact
although
cmv
caus
enceph
latter
extrem
rare
immunocompet
occur
sever
tcellmedi
immun
defici
approach
investig
possibl
role
cmv
ad
involv
examin
serum
antibodi
titr
viru
well
virus
bacteria
seek
relat
titr
occurr
ad
andor
chang
cognit
comprehens
earli
studi
renvoiz
et
al
gave
neg
result
adenoviru
chlamydia
group
b
coxiella
burnettii
hsv
influenza
influenza
b
measl
mycoplasma
pneumonia
well
cmv
titr
similar
ad
patient
control
pathogen
howev
recent
studi
presum
greater
sensit
strandberg
et
al
discov
viral
burdenseroposit
hsvi
cmvwa
associ
cognit
impair
among
homedwel
elderli
individu
vascular
diseas
mainli
coronari
heart
diseas
although
signific
associ
observ
bacteri
burden
chlamydia
pneumonia
cpn
mycoplasma
pneumonia
cognit
later
strandberg
et
al
found
maxim
increas
risk
cognit
impair
elderli
homedwel
associ
combin
three
factor
seroposit
herpesvirida
presenc
low
educ
data
indic
also
haplotyp
risk
factor
dementia
katan
et
al
similarli
investig
infecti
burden
ib
multiethn
elderli
subject
vascular
risk
measur
igg
level
helicobact
pylori
iga
cpn
cognit
miniment
state
examin
mmse
enrol
annual
telephon
interview
higher
ib
found
associ
wors
cognit
author
like
strandberg
et
al
conclud
effect
ib
cognit
mediat
viral
rather
bacteri
burden
howev
found
apo
effect
ib
respect
cognit
anoth
studi
tarter
et
al
examin
cmv
seroposit
rang
age
group
gener
popul
found
seroposit
children
associ
impair
cognit
middleag
impair
read
visuospati
process
slower
code
speed
among
older
adult
immedi
memori
impair
contrast
cmv
seroposit
associ
slower
code
speed
impair
learn
recal
middleag
therefor
suggest
might
lifecours
effect
cognit
cmv
effect
might
restrict
middleag
age
primari
infect
herpesvirus
affect
socioeconom
factorsris
increas
level
latterth
author
point
pathogen
might
contribut
lifelong
social
dispar
cognit
educ
attain
social
mobil
westman
et
al
examin
ad
patient
nondement
control
function
capac
cytokin
releas
profil
peripher
blood
mononuclear
cell
pbmc
respons
cmv
antigen
challeng
apo
genotyp
system
inflammatori
biomark
data
evid
studi
resid
brain
ad
patient
plu
epidemiolog
link
neg
cognit
effect
age
tarter
et
al
led
propos
cmv
deregul
inflammatori
respons
could
therebi
caus
frequent
prolong
reactiv
increas
risk
ad
altern
mechan
cmv
infect
might
directli
affect
ad
pathogenesi
increas
local
inflammatori
respons
variou
antigen
possibl
includ
increas
amyloid
precursor
protein
app
product
format
toxic
amyloid
protofibril
lead
cognit
declin
either
case
cmv
posit
inflammatori
promot
ad
immunolog
author
mention
conclus
consist
result
stow
et
al
latter
show
inform
studi
multiethn
subject
age
high
antibodi
titr
reflect
high
reactiv
rateswer
significantli
associ
cmv
seroposit
high
cmv
antibodi
level
also
increas
antibodi
level
age
occur
cmvseroposit
peoplejust
low
cmv
antibodi
level
sinc
individu
high
level
alreadi
high
level
occur
peopl
cmvseroneg
stow
et
al
conclud
cmv
influenc
immun
respons
pathogen
might
trigger
immun
dysregul
involv
agerel
diseas
suggest
specif
reactiv
associ
cmv
age
lurain
et
al
analyz
serum
cerebrospin
csf
fluid
associ
cmv
infect
ad
found
cmvspecif
serum
igg
antibodi
level
associ
nft
ad
brain
also
csf
interferon
detect
cmvseroposit
patient
also
percentag
senesc
cell
significantli
higher
cmvseroposit
seroneg
patient
although
author
consid
cmv
rather
implic
ad
see
comment
itzhaki
klapper
data
wholli
consist
concept
inflamm
caus
infect
affect
brain
result
reactiv
resid
cn
sever
studi
sought
antihsv
igm
well
igg
serum
ad
patient
basi
presenc
igm
associ
recent
reactiv
contrast
igg
show
person
infect
ad
though
serum
antibodi
level
reflect
respons
viru
peripheri
whether
reflect
also
respons
viru
cn
uncertain
howev
seem
like
event
caus
reactiv
peripheri
stress
immunosuppresss
would
caus
reactiv
also
brain
perhap
less
frequent
certainli
brain
might
much
difficult
detect
first
studi
antihsv
igm
letenneur
et
al
reveal
elderli
subject
igmposit
far
like
develop
dementia
within
follow
year
iggbut
igmposit
thu
support
concept
reactiv
viru
lead
eventu
dementia
subsequ
et
al
found
high
igm
level
igg
level
associ
low
plasma
level
consid
biomark
diseas
decreas
might
reflect
accumul
brain
cell
henc
reduct
plasma
level
although
author
consid
viru
reactiv
might
occur
consequ
initi
accumul
brain
rather
caus
accumul
nonetheless
conclud
data
support
involv
viru
reactiv
lead
alter
app
process
eventu
ad
associ
igm
posit
found
either
studi
author
tent
attribut
small
number
peopl
carrier
igmposit
altern
could
perhap
explain
case
appar
apo
effect
latter
determin
sever
damag
caus
reactiv
rather
occurr
frequenc
reactiv
see
eg
wozniak
et
al
et
al
carri
longitudin
prospect
cohort
studi
investig
possibl
relationship
hsv
infect
ad
examin
serum
antihsv
antibodi
sever
neuropsycholog
social
profession
featur
author
stress
studi
especi
strong
design
prospect
number
particip
larg
followup
durat
lengthi
diagnost
evalu
numer
first
cohort
peopl
recruit
follow
everi
year
thereaft
cohort
compris
around
peopl
recruit
year
year
year
later
one
case
particip
follow
everi
success
year
age
subject
rang
year
year
time
point
batteri
test
use
assess
particip
memori
system
problemsolv
decisionmak
abil
etc
health
examin
detail
result
consist
letenneur
et
al
et
al
reveal
presenc
antihsv
igm
antibodiesind
hsv
reactivationbut
presenc
igg
antibodi
almost
doubl
risk
ad
anoth
hsv
antibodi
studi
kobayashi
et
al
investig
igg
avid
index
ai
relat
cognit
function
ad
amnest
mild
cognit
impair
amci
avid
defin
strength
igg
attach
antigen
igg
avid
matur
length
time
follow
primari
infect
thu
igg
produc
within
first
month
primari
infect
exhibit
low
avid
wherea
igg
produc
sever
month
year
later
exhibit
high
avid
therefor
avid
distinguish
primari
infect
past
longlast
recurr
infect
author
took
ai
indic
reactiv
score
patient
mmse
frontal
assess
batteri
found
amci
higher
ai
healthi
control
surprisingli
higher
ad
patient
suggest
frequent
reactiv
occur
amci
group
also
igg
ai
igg
antibodi
titr
differ
control
amci
group
indic
involv
chang
healthi
state
onset
amci
appar
lower
reactiv
rate
ad
might
explain
occurr
structur
function
chang
brain
caus
agentsfactor
time
onset
confirm
ad
intrigu
variant
hsv
antibodi
studi
mancuso
et
al
examin
serum
igg
titr
patient
mild
ad
cortic
gray
matter
volum
measur
mri
expect
igg
level
similar
patient
agematch
normal
peopl
howev
high
antibodi
level
significantli
frequent
patient
correl
posit
cortic
bilater
tempor
orbitofront
gray
matter
volum
find
featur
specif
similar
analys
carri
cmv
antibodi
howev
correl
found
strengthen
case
involv
author
comment
damag
bloodbrain
barrier
bbb
might
enhanc
immun
cell
entri
suggest
antibodi
might
play
protect
role
earli
stage
ad
reduc
activ
brain
region
bbb
disrupt
sever
genom
wide
associ
studi
gwa
examin
genet
link
host
cell
gener
complex
paper
particularli
imagin
titl
licastro
et
al
review
recent
data
show
limit
number
gene
combin
strongli
associ
ad
even
though
effect
singl
gene
snp
weak
valu
ad
everi
case
less
apart
apo
suggest
gene
might
code
protein
interact
variou
process
thu
lead
synergist
effect
ad
pathogenesi
variou
possibl
mechan
consid
includ
environment
agent
trigger
certain
gene
might
affect
gene
therebi
caus
secondari
effect
via
apoptosi
immun
respons
etc
author
main
proposit
microb
particular
herpesvirus
might
well
link
snp
gwa
shown
associ
ad
thu
first
set
gene
found
locat
close
apo
locu
chromosom
second
set
locat
differ
chromosom
earlier
studi
porcellini
et
al
link
set
togeth
picalm
gene
suscept
herp
viru
infect
brain
third
set
five
gene
gave
support
viru
infect
hypothesi
gene
potenti
influenc
one
follow
process
viru
transport
brain
circul
within
viru
entri
neuron
regul
defenc
mechan
viru
host
immun
respons
cell
sensit
apoptosi
individu
suscept
infect
conclud
data
well
experiment
work
ad
other
studi
snp
gene
involv
variou
inflammatori
responsessom
associ
viral
infectionsthat
virus
herp
famili
among
probabl
pathogen
candid
respons
cn
neurodegener
old
age
carter
comment
bind
mani
cell
protein
therebi
modul
probabl
express
includ
mani
encod
suscept
gene
variou
neurolog
diseas
includ
ad
interactom
estim
gene
current
estim
total
proteincod
gene
number
close
associ
viral
interactom
diseas
suscept
gene
suggest
might
multipl
geneenviron
interact
would
allow
pathogen
caus
diseas
genet
suscept
individu
surprisingli
author
stress
point
seropreval
much
greater
diseas
perhap
milit
primari
causal
involv
even
though
subsequ
conced
host
microbi
genet
play
key
role
determin
outcom
infect
comment
also
even
though
viral
detect
antivir
drug
vaccin
might
affect
incid
mani
diseas
hostpathogen
protein
mimicri
suggest
effect
treatment
might
affect
autoimmun
featur
major
problem
studi
role
ad
current
lack
method
detect
reactiv
viru
particularli
postul
occur
limit
scale
local
region
cn
obvious
gross
damag
caus
hse
far
readili
detectablenowaday
seek
dna
csf
remain
week
start
outbreak
howev
number
case
report
hse
recur
month
year
initi
episod
suggest
might
fairli
frequent
occurr
subclin
enceph
mild
might
diagnos
correctli
klapper
et
al
interest
data
obtain
peter
seval
analyz
csf
specimen
subject
wide
rang
age
sent
refer
laboratori
hsv
test
found
overal
posit
age
group
ratio
infect
low
name
subject
femal
compris
male
femal
posit
femal
posit
almost
twice
mani
infect
detect
femal
male
comment
data
display
particular
bia
infect
femal
age
yearsan
intrigu
find
view
preponder
femal
ad
prepcr
studi
post
mortem
human
brain
specimen
strongli
suggest
reactiv
condit
immunosuppress
saldanha
et
al
brain
patient
acut
leukaemia
immunosuppress
part
treatment
examin
situ
hybridis
use
probe
strong
label
indic
presenc
dna
reveal
frontal
tempor
cortic
hsvseroposit
hsvseroneg
immunosuppress
incident
salient
point
made
view
subsequ
mandatori
usag
antivir
treat
hse
investig
unlik
ever
carri
significantli
review
multipl
sclerosi
patient
treat
natalizumab
hinder
inflammatori
cell
migrat
cn
reveal
novemb
decemb
case
develop
hse
fine
et
al
indic
presenceand
reactivationof
patient
brain
author
comment
treatment
case
led
patient
develop
progress
multifoc
leucoencephalopathi
caus
jc
viru
brain
normal
control
immun
system
howev
cn
opportunist
infect
rare
report
urg
greater
awar
risk
martin
et
al
examin
cn
trigemin
ganglia
mice
sever
marker
inflamm
neurodegener
aim
find
evid
asymptomat
reactiv
detect
viral
protein
acut
symptomat
phase
infect
day
also
day
postinfect
well
start
asymptomat
latent
phase
thu
indic
reactiv
occur
upregul
interferon
tolllik
receptor
tlr
occur
concurr
indic
neuroinflammatori
action
consist
previou
studi
show
activ
tlr
mous
astrocyt
cultur
villalba
et
al
arav
et
al
microgli
cell
phosphotau
tau
indic
earli
neurodegen
process
upregul
also
author
conclud
data
support
hypothesi
brain
reactiv
recurr
therebi
promot
neuroinflamm
trigger
tlr
activ
thu
confer
risk
neurodegener
interact
age
infect
gender
apo
mous
brain
investig
guzmansanchez
et
al
infect
monthold
male
femal
wildtyp
apoeknockout
mice
studi
follow
month
previou
work
group
burgo
et
al
burgo
et
al
shown
apo
determin
viral
load
cn
acut
latent
phase
infect
greater
anim
also
load
frontier
age
neurosci
wwwfrontiersinorg
august
volum
articl
femal
brain
greater
male
studi
found
viral
load
brain
maxim
acut
phase
declin
adulthood
increas
age
wildtyp
femal
mice
load
time
greater
apoeko
anim
surprisingli
detect
morpholog
patholog
differ
infect
mockinfect
old
anim
howev
infect
caus
memori
deficit
reduc
metabol
measur
neuron
health
author
comment
result
might
explain
data
indic
combin
brain
carriag
confer
strong
risk
ad
sy
et
al
postul
infect
might
promot
develop
ad
exacerb
preexist
neuroinflamm
henc
acceler
cognit
declin
induc
inflamm
mous
brain
viral
infect
lipopolysaccharid
latter
mimick
bacteri
infect
find
inflamm
modul
adlik
featur
develop
age
tripletransgen
mice
singl
dose
mous
hepat
viru
use
thu
caus
acut
infect
strong
neuroinflammatori
respons
found
immun
respons
mortal
differ
nontg
mice
accumul
occur
tau
phosphoryl
increas
mice
though
nontg
anim
increas
also
week
postinject
viral
infect
clear
shortterm
immun
respons
remain
also
later
stage
group
infect
mice
show
spatial
memori
impair
demyelin
spinal
cord
repeat
treatment
lp
induc
sustain
neuroinflamm
caus
chang
author
suggest
similar
effect
infect
might
occur
human
brain
therebi
exacerb
tau
patholog
featur
lead
ad
novel
studi
krut
et
al
compar
csf
biomark
profil
ad
variou
cn
infect
includ
hse
valu
ad
hse
contrast
infect
lyme
neuroborreliosi
bacteri
mening
hivassoci
dementia
show
markedli
similar
pattern
one
respect
level
lower
ad
hse
healthi
control
total
tau
ttau
hyperphosphoryl
tau
ptau
higher
ad
hse
control
none
valu
differ
significantli
ad
hse
patient
level
solubl
app
howev
significantli
lower
hse
ad
author
therefor
suggest
mechan
underli
disturb
metabol
two
disord
might
differ
similar
ptau
ttau
valu
might
indic
well
caus
hyperphosphoryl
tau
cell
cultur
see
caus
also
vivo
interest
overlap
protein
ad
protein
discov
zhou
et
al
analyz
total
protein
frontal
cortic
hiv
nondement
patient
protein
identifi
report
previous
sever
neurolog
diseas
includ
ad
refer
author
nonvir
diseas
comparison
hiv
despit
cite
sever
studi
ad
viral
aetiolog
inde
point
data
might
help
elucid
involv
pathogen
nonvir
neurodegener
author
two
preced
review
wozniak
itzhaki
itzhaki
wozniak
work
sever
laboratori
describ
show
infect
cultur
cell
includ
human
neural
cell
caus
mark
accumul
intracellular
ptau
also
deposit
form
brain
mice
wozniak
et
al
increas
explain
increas
relev
enzym
case
bace
occur
pkr
activ
consequ
phosphoryl
illraga
et
al
infect
primari
neuron
astrocyt
cultur
show
adlik
activ
tau
cleavag
lerchundi
et
al
de
chiara
et
al
examin
effect
infect
process
app
human
neuroblastoma
cell
rat
cortic
neuron
found
caus
multipl
type
cleavag
app
produc
action
enzymesprocess
occur
amyloidogen
pathwaylead
format
sever
potenti
neurotox
fragment
stress
cell
transfect
overexpress
app
data
might
well
close
simul
event
occur
vivo
specul
repeat
reactiv
viru
brain
fragment
might
play
major
role
pathogenesi
ad
anoth
type
approach
relat
app
pioneer
bearer
colleagu
studi
assembl
transport
discov
app
compon
isol
particl
app
molecul
present
particl
satputekrishnan
et
al
whether
app
present
viru
particl
within
cell
instead
join
isol
procedur
unknown
aim
recent
studi
investig
latter
also
find
whether
app
affect
viru
intracellular
transport
conversewheth
app
transport
affect
viru
result
obtain
use
gfptag
viru
show
app
coloc
travel
togeth
within
cell
distribut
app
abnorm
cell
bearer
point
nascent
profoundli
alter
cell
membran
organ
anterograd
transport
process
essenti
neuron
function
surviv
particularli
great
impact
case
chronic
infect
merit
sever
antivir
agent
differ
mechan
action
recent
investig
author
laboratori
respect
abil
reduc
ptau
product
commonli
use
antivir
acyclovir
acv
usual
administ
hse
suffer
prodrug
valacyclovir
vcv
much
greater
oral
bioavail
latter
effect
safe
acv
act
interf
replic
dna
target
specif
cell
contain
replic
action
requir
phosphoryl
viral
thymidin
kinas
tk
frontier
age
neurosci
wwwfrontiersinorg
august
volum
articl
monophosph
form
acv
phosphoryl
cellular
kinas
activ
triphosph
form
greater
affin
viral
cellular
dna
polymeras
acyclogtp
incorpor
viral
dna
caus
chain
termin
argu
acv
might
inhibit
accumul
ptau
format
depend
viral
dna
replic
fact
result
show
acv
also
penciclovir
foscarnet
two
agent
inhibit
viral
dna
replic
reduc
ptau
accumul
well
expect
vero
cell
cultur
howev
three
antivir
ptau
accumul
found
depend
dna
replic
wherea
accumul
antiviralinduc
decreas
instead
attribut
reduc
number
new
virus
form
henc
reduc
viral
spread
also
ptau
accumul
reduc
near
zero
wherea
reduc
nearnorm
valu
fact
lesser
reduct
seem
desir
view
possibl
might
function
least
initi
part
innat
immun
systemand
preliminari
data
suggest
inde
antivir
activ
klapper
et
al
prepar
although
eventu
becom
toxic
overproduc
word
treatment
perhap
aim
elimin
instead
reduc
nearnorm
levelsan
aim
achiev
acv
anoth
studi
acv
compar
antivir
bay
target
differ
stage
viral
dna
replicationth
helicaseprimas
complex
wozniak
et
al
found
bay
effici
acv
decreas
ptau
format
well
replic
infect
vero
cell
cultur
also
size
cell
cluster
form
infect
reduc
much
effici
bay
acv
data
suggest
bay
would
effect
acv
treat
ad
next
antivir
examin
intraven
immunoglobulin
ivig
reason
appar
benefici
action
ad
patient
might
result
antivir
action
rather
antibodi
also
antivir
act
infect
stage
viral
dna
replic
might
effect
treat
ad
ivig
seem
appropri
choic
studi
neutral
extracellular
viru
also
help
conjunct
lymphocyt
destroy
cell
acut
infect
found
wozniak
itzhaki
ivig
effect
reduc
accumul
ptau
infect
vero
cell
cultur
act
synergist
acv
suggest
use
combin
acv
would
benefici
treat
ad
amongst
mani
studi
vcv
action
vivo
one
possibl
relev
futur
clinic
trial
antivir
ad
conduct
rabbit
latent
infect
assay
extent
asymptomat
shed
dna
known
occur
anim
saliva
tear
similar
shed
saliva
tear
occur
also
human
effect
vcv
administ
rabbit
high
dose
mgkg
viral
dna
tear
examin
compar
dna
level
tear
collect
day
day
preinfect
day
postinfect
kumar
et
al
found
high
dose
vcv
treatment
significantli
reduc
copi
number
viral
dna
result
kumar
et
al
point
possibl
progress
antivir
treatment
ad
patient
could
monitor
assay
viral
level
tear
presum
saliva
alsothu
use
level
biomark
howev
far
clinic
trial
antivir
treatment
ad
patient
reason
applic
fund
refus
grantgiv
bodi
pharmaceut
compani
latter
presum
vcv
offpat
yet
evid
role
diseas
steadili
increasingand
everi
drug
test
fail
produc
magic
bullet
would
target
diseas
progress
thu
ad
remain
untreat
diseas
interestingli
vcv
found
allevi
cognit
impair
schizophrenia
patient
testofconcept
doubleblind
placebocontrol
trial
prasad
et
al
assess
effect
vcv
cognit
perform
psychopatholog
patient
age
year
given
g
vcv
twice
daili
given
placebo
week
addit
antipsychot
result
show
vcvtreat
subject
improv
verbal
work
memori
visual
object
learn
compar
placebo
group
author
point
although
proven
causal
associ
schizophrenia
data
indic
associ
viru
cognit
impair
especi
schizophrenia
studi
togeth
refer
strandberg
et
al
strandberg
et
al
katan
et
al
tarter
et
al
indic
viral
burden
especi
associ
decreas
cognit
provid
ammunit
concept
inde
respons
cognit
declin
ad
patient
intriguingli
memantin
nmethyldaspart
nmda
receptor
antagonist
use
treat
ad
either
combin
acetylcholinesteras
recent
shown
strong
antivir
activ
efficaci
memantin
ad
detail
individu
clinic
trial
metaanalys
recent
review
rive
et
al
found
particularli
import
reduc
agit
aggress
featur
common
usual
associ
earli
institution
caus
especi
great
stress
caregiv
author
therefor
conclud
memantin
provid
valuabl
treatment
ad
antivir
action
memantin
found
involv
nmda
receptor
discov
brison
et
al
drug
reduc
effect
mice
infect
human
neurovirul
coronaviru
caus
enceph
mutant
induc
paralyt
diseas
involv
glutam
excitotox
brison
et
al
found
memantin
act
interf
replic
viru
therebi
resembl
compound
deriv
adamantan
inhibit
viru
replic
amantidin
tromantadin
antihsv
antivir
therefor
propos
use
memantin
treat
certain
neurolog
diseas
possibl
viral
caus
ad
evid
present
presenc
elderli
human
brain
reactiv
interfer
frontier
age
neurosci
wwwfrontiersinorg
august
volum
articl
cellular
process
harm
effect
cognit
strong
evid
absenc
lack
associ
ad
present
three
year
year
ago
therefor
good
support
causal
factor
ad
howev
human
diseas
cell
anim
studi
provid
wholli
relev
inform
direct
experi
carri
vivo
absolut
proof
causat
would
success
prevent
diseas
vaccin
viru
reduct
diseas
progress
antivir
treatment
vaccin
would
given
earli
infanc
young
age
primari
infect
vaccin
would
follow
six
seven
decad
thereafteran
unrealist
possibl
leav
antivir
treatment
desir
safe
potenti
effect
altern
